HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of antisense monocyte chemoattractant protein-1 (MCP-1) in a rat model of mesangial proliferative glomerulonephritis.

AbstractOBJECTIVE:
The effects of inhibition of monocyte chemoattractant protein-1 (MCP-1) on a rat model of mesangial proliferative glomerulonephritis (MsPGN) were evaluated.
METHODS:
The anti-Thy-1 MsPGN model was developed by intravenously injecting anti-Thy-1 monoclonal antibodies into rats, followed by an injection of mesangial cells transfected with antisense MCP-1 into the renal artery. Exogenous cells were detected by in situ hybridization. Rats (40 total) were randomly divided into five groups: SO (sham operation), TG (Thy-1 glomerulonephritis model), MC (non-transfected normal rat mesangial cell), BC (pLXSN empty vector or blank control), and AM (antisense MCP-1 transfection) groups. Effects of exogenous MCP-1 on urinary protein excretion rate, biochemical parameters, and pathological changes were evaluated. Expression of MCP-1 and transforming growth factor-β1 (TGF-β1) were detected by immunohistochemistry. mRNA expression of MCP-1, TGF-β1, and CC chemokine receptor 2 (CCR2) were detected by RT-PCR.
RESULTS:
Exogenous MCP-1 cDNA was successfully transfected into mesangial cells. Exogenous mesangial cells were detected in glomeruli by in situ hybridization. Glomerular mesangial cell proliferation, 24-h urinary protein excretion rate, mRNA expression of MCP-1, TGF-β1, and CCR2, and protein expression of MCP-1 all decreased in the AM group as compared to the control group (p < 0.05), but there was no significant difference in the expression level of TGF-β1 protein.
CONCLUSIONS:
(1) Mesangial cells can be used as a vector to transfect exogenous genes into kidneys; (2) antisense MCP-1 decreases mesangial cell proliferation and pathological injury in MsPGN model rats by decreasing expression of MCP-1 and CCR2; and (3) antisense MCP-1 suppressed mesangial cell proliferation and matrix accumulation in anti-Thy-1 MsPGN model rats, which did not entirely depend on TGF-β1.
AuthorsHua Liu, Xin-Ping Zhang, Zhu-Wen Yi
JournalRenal failure (Ren Fail) Vol. 35 Issue 10 Pg. 1418-28 ( 2013) ISSN: 1525-6049 [Electronic] England
PMID23991758 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ccr2 protein, rat
  • Chemokine CCL2
  • DNA, Antisense
  • Isoantibodies
  • Receptors, CCR2
  • Tgfb1 protein, rat
  • Transforming Growth Factor beta1
  • anti-Thy antibody
Topics
  • Animals
  • Chemokine CCL2 (antagonists & inhibitors, metabolism)
  • DNA, Antisense (therapeutic use)
  • Disease Models, Animal
  • Female
  • Genetic Therapy
  • Glomerulonephritis, Membranoproliferative (drug therapy)
  • Isoantibodies
  • Mesangial Cells (metabolism)
  • Proteinuria (drug therapy)
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, CCR2 (metabolism)
  • Transforming Growth Factor beta1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: